Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
about
Monitoring immediate-early gene expression through firefly luciferase imaging of HRS/J hairless miceAnticytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zeyh.).Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression.RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.The immunological footprint of CMV in HIV-1 patients stable on long-term ARTMolecular targets for antiviral therapy of cytomegalovirus infections.Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.Inhibition of human cytomegalovirus immediate-early gene expression and replication by the ethyl acetate (EtOAc) fraction of Elaeocarpus sylvestris in vitro.Human cytomegalovirus may promote tumour progression by upregulating arginase-2.The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.Anti-human cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan).Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.Human cytomegalovirus immediate early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis.Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis.NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication.
P2860
Q24799895-E7FF2B51-2D2B-460A-AEA7-8E89A66BA298Q34649559-9915E8C8-03DC-4A0F-9807-F27175A899C8Q34975513-2C75A149-8AE8-423D-B278-696A9A95BB11Q35671858-2AA299A4-F28B-4598-B534-5AEF06D5DCD0Q35943427-7E427111-F377-4FF3-BF00-16035C5D9EEFQ36115162-B3DCD319-429D-4300-9E04-2D70BE9FF0DEQ37573779-2D01D7E8-CEF4-45F7-89E5-AED33BA9FD5AQ38018936-CB1CA609-B799-4327-9A94-432FBFA5B7F3Q38603414-7D0A7F2D-9769-4A16-8ECC-A97930F030F8Q38760685-84D6FF35-DE7E-46F0-8B40-903E298A34A1Q38962962-6356BF0A-F81D-4017-AEF3-5391157DF302Q39913684-31F5FC60-D6F9-4C6B-9F37-001EFFB56272Q40027571-8E813D45-56E3-4BE4-AB5F-2C5BA6E9A58BQ40334600-476021A0-9DAD-4D09-BE3D-69DF59FA70E9Q42242369-9B6911AF-AEB8-4141-84E7-D0B6DF73A28BQ42274183-16662196-1599-4425-BD3D-53AB8E96A242Q47249337-AB7D215F-BD54-4066-B2BC-FF7CC4B08DE0Q47861289-BA3D32AC-50AF-4C3E-8991-1A82C758B32EQ52954259-B5E856FB-D508-4A14-8A8C-F486BC3EB46CQ54413526-E413CF74-CF52-4BFA-80B9-FB0158A18701
P2860
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@ast
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@en
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@nl
type
label
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@ast
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@en
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@nl
prefLabel
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@ast
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@en
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@nl
P2093
P1433
P1476
Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?
@en
P2093
P304
P356
10.1016/S0166-3542(01)00126-7
P577
2001-03-01T00:00:00Z